Cytokinetics

+$0.97 (+2.50%) Today

$0.00 (0.00%) As of 8:26 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytokinetics and other ETFs, options, and stocks.

About CYTK

Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility.

CEO

Robert I. Blum

Employees

253

Headquarters

South San Francisco, California

Founded

1997

CYTK Key Statistics

Market cap

Price-Earnings ratio

—

Dividend yield

—

Average volume

1.04M

High today

$39.85

Low today

$38.05

Open price

$39.23

Volume

707.47K

52 Week high

$47.90

52 Week low

$17.72

CYTK News

MarketWatchMay 17

Cytokinetics: FDA Reverses Course, Plans AdCom Meeting on Omecamtiv Mecarbil - MarketWatch

By Colin Kellaher Cytokinetics Inc. on Tuesday said the U.S. Food and Drug Administration now plans to hold an advisory committee meeting on the company's prop

Analyst ratings

Buy

100%

Hold

Sell

CYTK Earnings

-$1.02

-$0.68

-$0.34

$0.00

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Estimated

— per share

Actual

Expected Aug 4, After Hours